Validity Reliability of 3 Meter Backward Walk Test in Stroke Patients

November 20, 2021 updated by: Ayşe Abit Kocaman, Kırıkkale University
The 3 m walk-back test is used to assess neuromuscular control, proprioception, protective reflexes, fall risk, and balance. In a study of healthy elderly adults, a 3-m walk-back test showed better diagnostic accuracy compared to the most commonly used measurement methods for falls in the past year. Reliability is extremely important, especially for research and clinical applications. In order to assess the risk of falling, measurement methods need to be reliable and change accurately over time. 3 m walk back test was found to be reliable in healthy elderly individuals. However, there are no studies investigating the validity and reliability of this test in stroke patients.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Balance; within the limits of the stability of the center of gravity can be controlled on the surface. Balance can be affected due to muscle weakness after stroke, abnormal muscle tone, loss of deep sensation and disturbances in vestibular mechanisms. Among all sensorimotor results of stroke, it is stated that the balance of postural control has the greatest effect on daily living activities and gait. Accurate assessment of balance in stroke patients is important in identifying appropriate aids for mobility, choosing an effective treatment program, determining safe and unsafe activities, and setting rehabilitation goals. The most common risk factor for falls is one of the most important risk factors for stroke. Therefore, reliable and accurate measurement of dynamic gait balance is an important issue in stroke patients.The 3 m walk-back test is used to assess neuromuscular control, proprioception, protective reflexes, fall risk, and balance. In a study of healthy elderly adults, a 3-m walk-back test showed better diagnostic accuracy compared to the most commonly used measurement methods for falls in the past year. Reliability is extremely important, especially for research and clinical applications. In order to assess the risk of falling, measurement methods need to be reliable and change accurately over time. 3 m walk back test was found to be reliable in healthy elderly individuals. However, there are no studies investigating the validity and reliability of this test in stroke patients.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kırıkkale, Turkey, 7110
        • Ayşe Abit Kocaman

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 40 years or older,
  • Getting a diagnosis of stroke,
  • Not having cooperation and communication problems
  • To be able to walk 10 m independently with or without device

Exclusion Criteria:

  1. Have a neurological or orthopedic problem other than stroke that will affect functionality and balance
  2. Individuals with contraindications for advanced cardiovascular disease and mobilization will not be included in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: stroke patients
Assessment
3-m backwards walk test, timed up and go test, 10 m walk test, Berg BalanceTest, Functional Reach Test

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
timed up and go test
Time Frame: first day
A standard chair is used for testing. First, the patient is asked to sit on the chair. The patient is then asked to stand up and walk regularly at a distance of 3 meters with a predetermined length, then return to the chair after 3 meters.
first day
3-m backwards walk test,
Time Frame: first day and second day
A distance of 3 m is measured and marked with black tape. Individuals are asked to follow the heel and black band. With the 'start' command they are asked to walk backwards quickly. When the distance of 3 m is completed, a stop is instructed. Individuals are not allowed to run during the test. They are allowed to look back if they wish. The assessor walks behind individuals throughout the test. The test is repeated 3 times, the averages are recorded
first day and second day
10 m walking test
Time Frame: first day
In this test, the individual is asked to walk at his / her normal speed within a pre-measured 10-meter area and is started when the individual is at the starting line of the foot and terminated when he crosses the finish line.
first day
Berg balance test
Time Frame: first day
The BBS consists of 14 items to directly monitor the maintenance of body balance during performance.
first day
Functional reach test
Time Frame: first day
It is used to measure both the balance of the individual functionally and the amount of dynamic reach.
first day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ayşe A Abit Kocaman, Kırıkkale University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 10, 2020

Primary Completion (Actual)

August 30, 2020

Study Completion (Actual)

September 11, 2020

Study Registration Dates

First Submitted

January 1, 2020

First Submitted That Met QC Criteria

January 11, 2020

First Posted (Actual)

January 18, 2020

Study Record Updates

Last Update Posted (Actual)

November 23, 2021

Last Update Submitted That Met QC Criteria

November 20, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Balance; Distorted

Clinical Trials on stroke patinets

3
Subscribe